Stocks and Investing Stocks and Investing
Tue, May 17, 2022

Matthew Harrison Maintained (BLUE) at Sell with Decreased Target to $3 on, May 17th, 2022


Published on 2024-10-27 21:07:28 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Sell with Decreased Target from $5 to $3 on, May 17th, 2022.

Matthew has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 6th, 2022
  • Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, April 6th, 2022
  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022


This is the rating of the analyst that currently disagrees with Matthew


  • Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 10th, 2022
Contributing Sources